glp 1 approval FDA Approves First Generic GLP-1 Liraglutide for Weight Loss New GLP-1 Pill Foundayo (Orforglipron)
Description
Currently available pediatric trials span roughly one year or less, and extension studies are ongoing
GLP-1 medications such as Wegovy, Ozempic, and Zepbound have become increasingly popular for treating obesity and Type 2 diabetes, but insurance coverage for these medications remains inconsistent and financially challenging for consumers who have resorted to getting their GLP1s through other avenues
The compounding of these medications is subject to evolving FDA enforcement posture and state pharmacy board oversight
Karagiannis, T
